| scholarly article | Q13442814 |
| P50 | author | Barbara Ensoli | Q21255143 |
| Giulia Marsili | Q56975243 | ||
| Anna Lisa Remoli | Q56975255 | ||
| Barbara Ridolfi | Q58137390 | ||
| Edvige Perrotti | Q63975601 | ||
| Marco Sgarbanti | Q37376901 | ||
| Ramona Ilari | Q44290764 | ||
| P2093 | author name string | Leonardo Sernicola | |
| Angela Battistini | |||
| Emilia Stellacci | |||
| Alessandra Borsetti | |||
| Roberto Orsatti | |||
| P2860 | cites work | Hostile takeovers: viral appropriation of the NF-kB pathway | Q22241900 |
| Activities of IRF-1 | Q24292304 | ||
| Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription | Q45230832 | ||
| Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription | Q45760530 | ||
| Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression | Q72037171 | ||
| Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors | Q24303448 | ||
| Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes | Q24568326 | ||
| Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors | Q24651506 | ||
| Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors | Q24674143 | ||
| Tat gets the "green" light on transcription initiation | Q24815711 | ||
| Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 | ||
| NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases | Q28215029 | ||
| HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure | Q28283258 | ||
| NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression | Q28286414 | ||
| IRF family of transcription factors as regulators of host defense | Q28513569 | ||
| Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B | Q29618096 | ||
| An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
| Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes | Q30428712 | ||
| Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes | Q33783041 | ||
| Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region | Q33809486 | ||
| Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat | Q34295016 | ||
| Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways | Q34325874 | ||
| Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase | Q34423659 | ||
| IRF regulation of HIV-1 long terminal repeat activity | Q34532710 | ||
| The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth | Q35888601 | ||
| Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. | Q35890307 | ||
| Differential transcriptional activation in vitro by NF-kappa B/Rel proteins | Q38298654 | ||
| Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter | Q38321481 | ||
| Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element | Q39721622 | ||
| Genetic analysis of NF- B/Rel transcription factors defines functional specificities | Q39962410 | ||
| Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1 | Q40016208 | ||
| T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region | Q40507856 | ||
| Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription | Q40950859 | ||
| NFkappaB activation is required for interferon regulatory factor-1-mediated interferon beta induction | Q40958716 | ||
| A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects | Q41484730 | ||
| Tumor necrosis factor-α, interleukin 1, and phorbol myristate acetate are independent activators of NF-κB which differentially activate T cells | Q41667500 | ||
| HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes | Q41687061 | ||
| Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. | Q41925734 | ||
| Activation of tat-defective human immunodeficiency virus by ultraviolet light | Q42809688 | ||
| A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. | Q42835385 | ||
| Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. | Q43709144 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 3632-3641 | |
| P577 | publication date | 2008-01-23 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer | |
| P478 | volume | 82 |
| Q34071264 | A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling |
| Q35347846 | A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection |
| Q54637559 | Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation |
| Q93051939 | Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus |
| Q41926635 | Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells |
| Q90512417 | Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide |
| Q45353751 | Diversity of caprine arthritis-encephalitis virus promoters isolated from goat milk and passaged in vitro |
| Q38917776 | ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease |
| Q38419101 | Early IFN type I response: Learning from microbial evasion strategies |
| Q36687211 | Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? |
| Q34707439 | Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals |
| Q40420307 | GERV: a statistical method for generative evaluation of regulatory variants for transcription factor binding. |
| Q64073812 | HERVs, immunity, and autoimmunity: understanding the connection |
| Q34009029 | HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production |
| Q37371813 | HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation |
| Q38204866 | HIV-1 latency: an update of molecular mechanisms and therapeutic strategies |
| Q34150444 | HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages |
| Q28570860 | Histone deacetylase-1 is enriched at the platelet-derived growth factor-D promoter in response to interleukin-1beta and forms a cytokine-inducible gene-silencing complex with NF-kappab p65 and interferon regulatory factor-1 |
| Q37922877 | Host factors mediating HIV-1 replication |
| Q24295849 | Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes |
| Q84790155 | IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation |
| Q38929174 | Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response |
| Q37051767 | In utero activation of fetal memory T cells alters host regulatory gene expression and affects HIV susceptibility |
| Q41885464 | Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs |
| Q28534057 | Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity |
| Q38170229 | Innate antiviral immune signaling, viral evasion and modulation by HIV-1. |
| Q37945237 | Innate antiviral response: role in HIV-1 infection |
| Q39708894 | Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination. |
| Q37643935 | IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes. |
| Q35120893 | NF-κB addiction and its role in cancer: 'one size does not fit all'. |
| Q37300387 | NF-κB and IRF1 Induce Endogenous Retrovirus K Expression via Interferon-Stimulated Response Elements in Its 5' Long Terminal Repeat |
| Q40650064 | Non-Metabolic Role of PKM2 in Regulation of the HIV-1 LTR. |
| Q91826055 | Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis |
| Q34038531 | Oral infectious diseases: a potential risk factor for HIV virus recrudescence? |
| Q41135535 | Promoter type influences transcriptional topography by targeting genes to distinct nucleoplasmic sites |
| Q35252396 | Reactivation of latent HIV-1 by new semi-synthetic ingenol esters |
| Q51589369 | Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1. |
| Q36939732 | Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation |
| Q34516863 | Regulatory evolution of innate immunity through co-option of endogenous retroviruses |
| Q54209057 | SIV Latency in Macrophages in the CNS. |
| Q27657031 | Structural Basis of HIV-1 Activation by NF-κB—A Higher-Order Complex of p50:RelA Bound to the HIV-1 LTR |
| Q34033566 | Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages |
| Q34091270 | TRAF6 and IRF7 control HIV replication in macrophages |
| Q27317391 | The simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivo |
| Q42280405 | Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells |
| Q37168039 | Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages |
Search more.